April A. N. Rose

2.9k citations
57 papers · 1.9k indexed · 1 hit paper · h-index 21
Topics
Melanoma and MAPK Pathways (16 papers)HER2/EGFR in Cancer Research (10 papers)Lung Cancer Treatments and Mutations (7 papers)
Partner nations
CanadaUnited StatesJapan

In The Last Decade

April A. N. Rose

52 papers receiving 1.9k citations

Hit Papers

Classifying BRAF alterations in cancer: new rational ther...20182026202020232018100200300

Peers

April A. N. Rose
Comparison fields: 5 of 102
  • Oncology 998
  • Molecular Biology 958
  • Pulmonary and Respiratory Medicine 372
  • Immunology 336
  • Cancer Research 307
Replace Michael Lahn with:
Michael Lahn United States
Mari Iida United States
Nandini Dey United States
Ka Yin Kwong United States
Teresa C. Dugger United States
Niranjan Awasthi United States
Gert G. Van den Eynden Belgium
Joan T. Garrett United States
Nila U. Parikh United States
Jonathan M. Yingling United States
April A. N. Rose relative to Michael Lahn United States Michael Lahn's profile →
Citations per field
00.5×1.5×
Michael Lahn · 1×
Citations per year

Countries citing papers authored by April A. N. Rose

Since Specialization
Citations

This map shows the geographic impact of April A. N. Rose's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by April A. N. Rose with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites April A. N. Rose more than expected).

Fields of papers citing papers by April A. N. Rose

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by April A. N. Rose. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by April A. N. Rose. The network helps show where April A. N. Rose may publish in the future.

Co-authorship network of co-authors of April A. N. Rose

This figure shows the co-authorship network connecting the top 25 collaborators of April A. N. Rose. A scholar is included among the top collaborators of April A. N. Rose based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with April A. N. Rose. April A. N. Rose is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 2
3 2
4 2
5 7
6 11
7 3
8 4
9 19
10 16
11 26
12 1
13 0
14 47
15 96
16 68
17 157
18 168
19 21
20
Functional requirement for RGD and PKD domains of GPNMB in breast cancer metastasis
2

About April A. N. Rose

April A. N. Rose is a scholar working on Oncology, Immunology and Allergy and Pulmonary and Respiratory Medicine, having authored 57 papers that have together received 1.9k indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (16 papers), HER2/EGFR in Cancer Research (10 papers) and Lung Cancer Treatments and Mutations (7 papers). The work is most often cited by research in Oncology (998 citations), Cancer Research (307 citations) and Immunology and Allergy (109 citations). April A. N. Rose has collaborated with scholars based in Canada, United States and Japan. Frequent co-authors include Peter M. Siegel, Matthew Dankner, Ian R. Watson, Matthew G. Annis, Shivshankari Rajkumar, Michael Hallett, François Pépin, Caterina Russo, Zhifeng Dong and Morag Park. Their work appears in journals such as Journal of Clinical Oncology, Nature reviews. Cancer and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026